- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Dyax Corp+ Add to Watchlist
DYAX:US9.0100 USD 0.2500 2.85%
As of 20:10:00 ET on 07/10/2014.
Company Profile for Dyax Corp (DYAX)
Dyax Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of antibodies, small proteins and peptides as therapeutic products for unmet medical needs, particularly in the areas of inflammation and oncology. The Company currently has two recombinant proteins, DX-88 and DX-890 in phase II clinical trials.
Key Executives for Dyax Corp (DYAX)
|Gustav A ChristensenPresident/CEO||George V MigauskyExec VP/CFO|
|Burt A AdelmanExec VP/Chief Medical Ofcr||Andrew AsheExec VP/General Counsel|
|Nicole JonesDir:Investor Relations|